Preparing for sperm-targeted contraception: College students' perceptions and intentions related to non-hormonal intravas injectable gel.
OBJECTIVE
The objective of the study was to evaluate college students' perceptions and behavioral intentions related to a new long-acting reversible contraceptive (LARC) for people with penises: non-hormonal intravas injectable gel (NH-IVIG).


DESIGN AND SAMPLE
Data collection utilized predictive constructs from the theory of planned behavior. An online questionnaire surveyed undergraduates (ages 18-24 years) at a Midwestern, liberal arts college (N = 460).


RESULTS
Of potential NH-IVIG users, 28.6% of males and 51.4% of females reported being overall likely to use or encourage its usage. The top three hypothetical NH-IVIG promoters were low cost, reversibility, and infrequent administration. High cost, new product uncertainties, plus administration via injection for the males, were the most frequently cited NH-IVIG deterrents. A majority of potential users indicated intentions to use protective barriers or other contraceptives simultaneously with NH-IVIG; females were more likely overall. Most respondents (males, 90.4%; females, 98.5%) agreed all sexual partners should be equally responsible for contraception. Over half trusted both males and females to use contraception, but females were significantly more trusted and trusting.


CONCLUSION
Understanding factors influencing NH-IVIG usage can direct initiatives for sperm-targeted LARCs to mitigate risk behaviors and optimize public health promotion.
['Buck|Kirstin A|KA|0000-0003-3407-9741', 'Stadick|Jessica L|JL|', 'Frazier|Marian L|ML|']
D000293:Adolescent D003268:Contraception Behavior D005260:Female D005782:Gels D006801:Humans D007267:Injections D033182:Intention D000075523:Long-Acting Reversible Contraception D008297:Male D015146:Midwestern United States D010465:Perception D013094:Spermatozoa D013334:Students D011795:Surveys and Questionnaires D014495:Universities D055815:Young Adult
LARC RISUG Vasalgel health behaviors male contraception